Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα

Similar documents
Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

ECG in CRT patients & novel HF therapies. Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?

What s new in my specialty?

This is What I do to Improve CRT Response for CRT Non-Responders

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Interventional solutions for atrial fibrillation in patients with heart failure

14ο Βορειοελλαδικό Καρδιολογικό Συνέδριο ΚΕΒΕ Βηματοδότηση: Νεότερες εξελίξεις Προοπτικές

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

Θα πρέπει να αναζηηείηαι η παροσζία ζιωπηλής κολπικής μαρμαρσγή ζε αζθενείς με κρσπηογενές εγκεθαλικό επειζόδιο; Ποιά είναι η καλύηερη μέθοδος;

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

How do I convert my CRT Non Responder into Responder?

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

First question: Does CRT Work in AF?

EBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Outcomes of AF Ablation

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Cardiac Imaging in abnormal rhythm Role of MDCT

Rebuttal. Jerónimo Farré MD 2010

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Multisite Left Ventricular Pacing for Cardiac Resynchronization

A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE

Large RCT s of CRT 2002 to present

ESC Stockholm Arrhythmias & pacing

Atrial Fibrillation Ablation in Patients with Heart Failure

Rate and Rhythm Control of Atrial Fibrillation

Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation?

Catheter ablation in AF patients with heart failure. What is possible?

Atrial Fibrillation Ablation in Patients with Heart Failure

Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή;

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

Atrial Fibrillation New Approaches, Techniques, and Technology

علم االنسان ما لم يعلم

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing

3/25/2017. Program Outline. Classification of Atrial Fibrillation

AF ABLATION Concepts and Techniques

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Role of LAA isolation in AF cure

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Bi-Ventricular pacing after the most recent studies

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients

Technical Considerations Prior to CRT Implant: Quadripolar LV Lead, Adaptive CRT and Something Else? 2015 Update

Abstract nr. 1 Abstract code Hybrid Versus Catheter Ablation for Atrial Fibrillation: the HARTCAP-AF Trial

Device detected AF and atrial high rate episodes

INNOVATIONS IN DEVICE THERAPY:

ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure

Atrial Fibrillation Ablation: in Whom and How

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Supplementary Online Content

Cryptogenic Stroke: The role of silent Atrial Fibrillation

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France

Summary, conclusions and future perspectives

UTILITY OF THE IMPLANTABLE LOOP RECORDER

Long Standing Persistent AF ; CPVI is enough for it

Importance of CRT team for optimization of the results: a European point of view

ΑΣΥΜΠΤΩΜΑΤΙΚΗ ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ

How to Approach the Patient with CRT and Recurrent Heart Failure

Device based CRT optimization: is there a future? Lessons learned from published trials

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

The Effect of Vagus Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing

Fibrillation Atriale Paroxystique : ablation, résultats, complications

Cardiac Resynchronization ICD Therapy: What is New?

EP WIRE on Management Preexcitation syndromes

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese

Atrial Fibrillation 2009

Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ

Surgical Ablation for Lone AF: What have we learned after 30 years?

Management of Atrial Fibrillation in Heart Failure

Diagnosing atrial fibrillation using implantable devices

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

When does enhanced monitoring for atrial fibrillation add value?

Rate vs. Rhythm Control in Atrial Fibrillation

Recurrent refractory ventricular tachycardia in a patient with LVAD

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

Cardiac resynchronization therapy for heart failure: state of the art

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

Consensus document: Screening and Prevention of Atrial Fibrillation

Targeting the late sodium channel: A new antiarrhythmic paradigm?

His Bundle Pacing in Bundle Branch Block May 11, 2017

Thoranis Chantrarat MD

Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF)

Catheter Ablation for AF: Patients, Procedures, Outcomes

Transcription:

Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα 2015-2016 Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος

Dr. Konstantinou has received grants from Medtronic

Presentation outline Paroxysmal AF Cryoballoon vs. RF ablation of pulmonary veins -Freeze-AF, FIRE AND ICE Contact Force sensing vs. standard RF ablation catheters -TOCCASTAR, EFFICAS II Persistent AF Pulmonary vein isolation vs. additional substrate modification -STAR-AF Silent AF Implantable Loop Recorders vs. conventional ECG monitoring techniques -CRYSTAL-AF

Presentation outline (cont.) Pharmacotherapy for paroxysmal AF Low dose dronedarone + moderate dose ralonazine -The Harmony Trial Improving CRT response rates Emerging CRT algorithms -AdaptivCRT Multipoint Pacing -IRON-MPP registry Primary prevention of sudden cardiac death The role of prophylactic ICD implantation in DCM -DANISH trial

Cryoballoon vs. Radiofrequency ablation of pulmonary veins

N Engl J Med 2016;374:2235-45

Primary efficacy endpoint: 1. recurrence of AF (lasting >30 s), 2. occurrence of Afl/AT, 3. prescription of class I/III AADs or 4. repeat ablation N Engl J Med 2016;374:2235-45

treatment of patients with drug-refractory paroxysmal AF, PV isolation by means of CB ablation was non-inferior to RF ablation in terms of efficacy and safety. N Engl J Med 2016;374:2235-45

Contact force-sensing ablation catheter vs. standard, non-force-sensing catheter

Circulation. 2015;132:907-15

CF-sensing ablation catheter was non-inferior to the standard non force-sensing catheter with respect to shortand long-term efficacy and safety. The use of optimal CF (>10 g) was associated with higher success. Circulation. 2015;132:907-15

Contact Force (CF) guidelines: 1. target CF of 20 g (range 10 30 g) AND 2. minimum Force-Time Integral of 400 gs Continuity Index (CI) assessment* *no guidance on CI was given to operators Europace 2015;17:1229-35

Conduction gaps were assessed by remapping of PVs after 3 months Europace 2015;17:1229-35

In EFFICAS II, PV lines isolated initially with a CI<6 (low CI) had a 98% chance of remaining isolated.

Pulmonary vein isolation vs. additional substrate modification in persistent AF

N Engl J Med 2015;372:1812-22

Among patients with persistent AF, we found no reduction in the rate of recurrent AF when either linear ablation or ablation of complex fractionated electrograms was performed in addition to pulmonary-vein isolation. More extensive ablation may cause new, iatrogenic areas of arrhythmogenesis where tissue is incompletely ablated or linear block is not achieved. Perhaps neither complex electrograms nor lines are the correct supplemental targets for ablation N Engl J Med 2015;372:1812-22

Facts: 1. Up to 40% of ischemic strokes initially classified as cryptogenic 2. Silent AF is present in 30% of cryptogenic stroke patients 3. Standard 24-hour Holter monitoring limited sensitivity for the detection of new AF (2%-6%) Circ Arrhythm Electrophysiol. 2016;9:e003333

Implantable Loop Recorders

In conclusion, extended long-term monitoring with an ICM uncovered AF in a high proportion of patients with prior CS or TIA. Detection of AF resulted in OAC therapy prescription in the majority of patients. Circ Arrhythm Electrophysiol. 2016;9:e003333

All patients had a DDD pacemaker implanted for standard clinical indications before enrollment All devices had atrial arrhythmia detection algorithms+egm storing capacity Circ Arrhythm Electrophysiol. 2015;8:1048-56

Combining 2 drugs with complementary electrophysiological properties (increased efficacy) at lower doses (decreased toxicity) Multi-channel blockade Contraindicated in HF due to negative inotropism from block of L-type Ca ++ channels (concentration dependent) Lower doses should be less cardio-depressant Late Na + current inhibition decreases cellular Na + & Ca ++ loading thereby EAD and DAD occurrence

moderate dose ranolazine combined with reduced dose dronedarone can decrease AF yet maintain good tolerance/safety in the population enrolled. Circ Arrhythm Electrophysiol. 2015;8:1048-56

THERE ARE OPPORTUNITIES TO IMPROVE CRT RESPONSE POTENTIAL REASONS FOR SUBOPTIMAL CRT RESPONSE 1 1 Mullens W, et al. J Am Coll Cardiol. 2009;53:765-773. 24 Claria MRI Quad SureScan CRT-D Customer Presentation

ADAPTIVCRT ALGORITHM OPERATION LV pacing can be at least as efficacious as BiV pacing In patients with SR and normal AV conduction, pacing only the LV with appropriate AV intervals can result in even superior LV and RV function compared with standard BiV pacing The algorithm is intended to provide ambulatory CRT optimization, allow more physiologic ventricular activation and greater device longevity in patients with normal AV conduction by reducing unnecessary RV pacing 25 Claria MRI Quad SureScan CRT-D Customer Presentation

Heart Rhythm 2012;9:1807 14

43.8% absolute reduction in RV pacing The acrt algorithm was safe and at least as effective as BiV pacing with comprehensive echocardiographic optimization across a variety of endpoints. Heart Rhythm 2012;9:1807 1814

% patient improved in Clinical Composite Score ADAPTIVCRT IMPROVES PATIENT OUTCOMES BY Improving CRT Response by 12% 1 For patients in sinus rhythm, with normal AV conduction and LBBB 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 81% p = 0.041 69% Normal AV AdaptivCRT Echo-optimised CRT AdaptivCRT: Produced mostly synchronized LV pacing (73% +/- 25%) Resulted in better clinical response at 6 months (81% vs. 69%) 1 Birnie D, et al. Heart Rhythm. 2013;10:1368-1374.. 28 Claria MRI Quad SureScan CRT-D Customer Presentation

ADAPTIVCRT IMPROVES PATIENT OUTCOMES BY Providing a 46% reduction in AF risk *1 For all patients * Compared to echo-optimized BiV pacing. 1 Martin D, et al. Clinical Outcomes with Adaptive Cardiac Resynchronization Therapy: Long-term Outcomes of the Adaptive CRT Trial. HFSA Late Breakers. September 23, 2013. 29 Claria MRI Quad SureScan CRT-D Customer Presentation

ADAPTIVCRT IMPROVES PATIENT OUTCOMES BY Reducing a patient s odds of a 30-Day HF Readmission * by 59% 1 For all patients * Readmissions following an HF hospitalization. 1 Starling RC, Krum H, Bril S, et al. Impact of a Novel Adaptive Optimization Algorithm on 30- Day Readmissions: Evidence From the Adaptive CRT Trial. JACC Heart Fail. July 2015;3(7):565-572. 30 Claria MRI Quad SureScan CRT-D Customer Presentation

THERE ARE OPPORTUNITIES TO IMPROVE CRT RESPONSE POTENTIAL REASONS FOR SUBOPTIMAL CRT RESPONSE 1 1 Mullens W, et al. J Am Coll Cardiol. 2009;53:765-773. 31 Claria MRI Quad SureScan CRT-D Customer Presentation

MULTIPLE POINT PACING OPTION TO IMPROVE CRT RESPONSE IN SOME NON-RESPONDERS Multiple Point Pacing allows to pace from 2 LV electrodes instead of one. Potential benefits of Multiple Point Pacing: Capture a larger area of the LV Engage areas around scar tissue Improve pattern of de/repolarization Improve acute/chronic hemodynamics Improve resynchronization Several small studies have been shown that Multiple Point Pacing is safe 2,3 and resulted in similar or better acute hemodynamics 4-8 and better chronic outcomes 5 versus standard BiV pacing. Multiple Point Pacing may benefit non-responders compared to standard CRT 1. 32 Claria MRI Quad SureScan CRT-D Customer Presentation

Compared with conventional CRT, MPP resulted in an additional increase in ejection fraction and clinical composite response. Europace 2016 doi:10.1093/europace/euw094

How to choose the optimal vector/timing? Europace 2016 doi:10.1093/europace/euw094

The results revealed different practices among centers, and establishing the optimal programming in order to maximize the benefit of MPP remains a challenging issue. Europace 2016 doi:10.1093/europace/euw094

DOI: 10.1056/NEJMoa1608029

All time-to-event curves appeared to diverge during the initial 5 years of the trial and then to converge DOI: 10.1056/NEJMoa1608029

31% of deaths due to noncardiovascular causes DOI: 10.1056/NEJMoa1608029

Patients with nonischemic HF may be less prone to death from arrhythmia than patients with ischemic HF better medical treatment and CRT also may have reduced the risk of death from arrhythmia for all patients with HF. At present, it is therefore unclear whether patients who are eligible for CRT should routinely receive an ICD. the benefit of ICD implantation with respect to sudden cardiac death is convincing, and patients who are not expected to die from other causes may be good candidates for ICD implantation. DOI: 10.1056/NEJMoa1608029

Take Home Messages In paroxysmal AF, PV isolation by means of CB ablation is non-inferior to RF ablation in terms of efficacy and safety -shorter procedural time, steeper learning curve -longer fluoroscopy time, more phrenic nerve palsy (usually resolves spontaneously) In paroxysmal AF, CF-sensing ablation catheter is non-inferior to the standard non force-sensing catheter with respect to short- and longterm efficacy and safety -incorporating CF guidelines (i.e. CF of 20g AND min FTI of 400gs) and aiming for contiguous lesion formation (low continuity index<6), initial PV lines have a 98% chance of remaining isolated after 3 months

Take Home Messages In persistent AF, adding linear ablation or ablation of complex fractionated electrograms to standard pulmonary-vein isolation did not reduce the rate of recurrent AF In patients with prior CS or TIA, extended long-term monitoring with an ICM uncovered AF almost 9 times more often compared to conventional monitoring which resulted in OAC therapy prescription in the majority of cases Moderate dose ranolazine combined with reduced dose dronedarone can decrease AF yet maintain good tolerance/safety

Take Home Messages The acrt algorithm was safe and at least as effective as BiV pacing with comprehensive echocardiographic optimization -Superior clinical outcomes may be expected in patients with SR, normal AV conduction and LBBB Compared with conventional CRT, MPP resulted in an additional increase in ejection fraction and clinical composite response -establishing the optimal programming in order to maximize the benefit of MPP remains a challenging issue Prophylactic ICD implantation in symptomatic DCM patients did not reduce long-term mortality but -it did halve the risk for sudden cardiac death overall -it did reduce all cause mortality in younger patients

Ευχαριστώ πολύ για την προσοχή σας!